CGM Credentialing: The “Class II” Device Rules That Pharmacy Licenses Miss

Answer Summary:

Continuous Glucose Monitors (CGMs) are Class II medical devices, yet many pharmacies attempt to dispense them under a standard pharmacy license. In 2026, regulators and payers are enforcing strict DMEPOS Accreditation requirements for CGMs. To bill Medicare and commercial plans for these high-value sensors, providers must add the specific “Monitors” product category to their accreditation and hold a valid DME state license, separate from their pharmacy permit.

Introduction:

The “Gold Rush” of 2026 is undoubtedly Continuous Glucose Monitors (CGMs). As coverage expands to non-insulin users, the volume is skyrocketing.

Pharmacies naturally want in.

But here is the stop sign: A CGM is not a drug. It is a Class II Medical Device.

If you treat it like a prescription drug, you will face a “Licensure Audit” that recoups every dollar.

The Accreditation Gap

Many providers have a “General DME” accreditation.

• The Trap: Does your accreditation specifically list code A9276/A9277 (Sensors/Transmitters)?
• The Risk: If your accreditation is for “Canes and Crutches,” you are billing out of scope.
• The Fix: You need to file an “Add-Product” application with your Accrediting Organization (AO) immediately.

The “Records” Requirement

DME rules are different from Pharmacy rules.

• Pharmacy: “Here is the pill bottle. Have a nice day.”
• DME (CGM): You must prove “Patient Education.” Did you teach them how to use the sensor? Did you document the serial number?
• The Audit: Payers are requesting “Proof of Delivery” that includes serial numbers. Standard pharmacy POS systems often don’t capture this.

WWS Value Proposition:

We Credential You for the CGM Boom

Don’t let a missing category code stop your growth. Wonder Worth Solutions manages the Category Addition process. We update your 855S enrollment, file the expansion request with your AO, and ensure your state licenses cover Class II devices.